Revolutionizing Oncology: T Cells As Predictive Powerhouses in Skin Cancer

0 Просмотры
A pioneering study reveals that Vd1-gd T cells can indicate a patient’s likelihood of responding to cancer immunotherapies, paving the way for more targeted and effective treatments.

A type of immune cell can help predict which patients may benefit most from cancer immunotherapies, researchers from King’s College London, Guy’s and St Thomas’ Hospital Trust, and the Francis Crick Institute have found.

The study, published on January 3 in Nature Cancer, found that a rare type of T cells (a type of immune cell), can help predict the likelihood of whether a patient with advanced skin cancer will be responsive to immunotherapy treatments. The results could also lead to the development of new and more effective treatments for patients with melanoma who do not benefit from current immunotherapies.
Комментариев нет.